Tandem Therapeutics

✨ What a great experience being part of Wyss Zurich Annual Event 2024! Tandem Therapeutics, as the youngest project in the Wyss portfolio, it was humbling to be among accomplished peers. The inspiring panel on resilience headlined by Hansjörg Wyss, Dominik Escher, Carla Kriwet & Felix Mayer, moderated by Roland Siegwart & Simon P. Hoerstrup reminding us to embrace challenges as opportunities for growth. 🚀We are eager to apply these insights to our journey and continue pushing boundries in targeted therapies for fibrosis! Mamta Chabria, PhD , Viola Vogel, Jodi Williams, PhD,David Lauer, Wanja Staubli

🌟 We are excited to welcome David Lauer, to the Tandem Therapeutics team as our new Scientist! 🌟   With an in-depth background in lung #fibrosis, extracellular matrix biology, and immunology, David makes a perfect addition to our team.   At Tandem Therapeutics, we are committed to “unlocking the matrix barrier to treat fibrotic diseases”. As part of Project Tandem at Wyss Zurich, David will be instrumental for driving in vitro and in vivo translational work of our novel drug candidates, focused on alleviating the fibrotic burden through innovative matrix remodelling strategies.   We are excited for the impact David will have on our journey, and wish him a great start! #fibrosis #extracellularmatrix #targeted #peptides

A first for Tandem Therapeutics to participate as an exhibitor at Festival of Biologics, Basel. The event featured insightful sessions and dynamic panel discussion, providing valuable opportunities to connect with industry leaders in #ADC development. As pioneers in advancing #targeted Peptide Drug Conjugates #PDCs aimed at halting #fibrosis progression, we gained significant insights from the challenges faced by ADCs, allowing us to enhance our approach and continue driving innovation in this nacent field. #fibrosis #extracellularmatrix #peptides #festivalofbiologics

We are thrilled to share stage with other amazing Swiss Biotechs. Thank you Venturelab for fuelling our zeal to develop novel extracellular matrix #targeted #therapies for fibrotic diseases. #peptides #ecm #ILD

We are thrilled to announce the addition of Jodi Williams, PhD to our team as Director, Medicinal Chemistry! With an impressive career spanning 17 years in the pharmaceutical industry, Jodi brings a wealth of knowledge, experience, and passion for innovation that perfectly aligns with our vision and mission at Tandem Therapeutics.   Throughout his career, Jodi has been at the forefront of groundbreaking research & development, contributing to numerous successful projects. His expertise in #drug #discovery, development and optimization will be vital as we continue to push the boundaries of what is possible in the field of #extracellular #matrix targeting in #fibrosis.   At Tandem Therapeutics, we are dedicated to “unlocking the matrix barrier to treat fibrotic disease”. In the scope of Project Tandem at Wyss Zurich, Jodi will spearhead the development of novel modalities i.e, peptide drug conjugates to remodel the fibrotic matrix to potentially halt fibrosis progression.   We are excited for this new chapter and look forward to achieving great things with Jodi leading our medchem efforts.  Welcome Jodi!

📣 We are hiring!! 📣 We are looking for Scientist/Senior Scientist to join our "small but mighty team" 💪 disrupting fibrosis treatments by targeting extracellular matrix. Be a key player, drive innovation and shape the future of fibrosis as a part of Wyss Zurich https://lnkd.in/e4AQg3w4 #FibrosisResearch #ECM #ETH #Startup

🌟 Reflecting on an unforgettable evening 🌟 Looking back on our #devigier award ceremony, we're filled with pride and gratitude. This year, the judges faced tough decisions, leading to an unexpected yet wonderful outcome: six deserving winners instead of the usual five! 🎉✨ The sixth prize was donated by the Medien- und Unternehmungsförderungsstiftung FERS from Berne 💛 Thank you! And many thanks to Simon Ittig for taking us back in time, offering authentic and encouraging insights into his very successful startup journey. Our six winners are impressive personalities, each bringing game-changing solutions for our society. Let's also remember the four outstanding nominees who didn't win this time. We have no doubt we'll be seeing great things from them in the future. 🌟💪 A big thank you to everyone who made this event possible – together, we're driving forward the future of innovation and entrepreneurship in our country 🚀 🇨🇭 And last but not least: bye bye dearest Carmen Lamparter, to new adventures (literally - she's going on a road trip through Africa with her husband and young child 🚗 🌍)! You have been a wonderful COO. #SwissStartups #Innovation #Entrepreneurship #Awards #FutureLeaders apheros Ascento EVIIVE Grensol Group Neology Hydrogen Optiml PEROVSKIA SOLAR AG Tandem Therapeutics Tethys Robotics Treeless Pack André Hoffmann Guy Petignat Wolfgang Heutschi Pirmin Bischof Felix Grisard Carolyn J. Lutz Alain Nicod Theresa Visarius Hanna Byland jump-tv https://lnkd.in/eu8-3TgC

Learn more about our journey so far in this interview with Tandem Therapeutics CEO, Mamta Chabria, PhD

„This year, we’ve had the ✨ privilege ✨ of meeting a group of extra captivating personalities. It’s been an inspiring journey to witness their dedication and energy in shaping a better future“, says Carmen Lamparter, COO of the W.A. de Vigier Foundation. 👉 👉 Meet the 10 nominees in the running for up to 5 #devigier awards! 🗓 Don't forget to mark your calendars: The award ceremony will be live-streamed at devigier.ch on June 19th.

We’re excited to share that we’ve been accepted into Wyss Zurich as an official project! ✨ As of 1st April 2024, we’ve been busy being onboarded and getting to know our new support environment better. Now with access to world-class #infrastructure and #experts, as well as financial backing, we are eager to advance our translational #R&D efforts to develop novel peptide #drug conjugates to target precisely and treat fibrosis-driven diseases. Read the full press release 👇 #wysszurichproject #pressrelease #precisionmedicine #fibrosis #fightingfibrosis #fibrosistreatment #ecm